Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
AngioDynamics, Inc. (ANGO) had Weighted-Average Shares Outstanding (Diluted) of 41.60M for the most recently reported fiscal quarter, ending 2026-02-28.
| Income Statement Financials | |
$78.42M |
|
$-8.08M |
|
$36.94M |
|
$41.48M |
|
$91.37M |
|
$-12.95M |
|
$4.88M |
|
$-8.07M |
|
$-8.07M |
|
$-8.08M |
|
$-8.08M |
|
$-8.08M |
|
$-8.08M |
|
$-12.95M |
|
$-7.36M |
|
41.60M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
41.60M |
$-0.19 |
|
$-0.19 |
|
| Balance Sheet Financials | |
$155.55M |
|
$29.14M |
|
$105.13M |
|
$260.68M |
|
$66.07M |
|
-- |
|
$21.25M |
|
$87.32M |
|
$173.36M |
|
$107.87M |
|
$173.36M |
|
41.68M |
|
| Cash Flow Statement Financials | |
$-14.36M |
|
$-4.68M |
|
$0.67M |
|
$55.89M |
|
$37.81M |
|
$-18.08M |
|
$10.04M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.35 |
|
-- |
|
-- |
|
-- |
|
-- |
|
52.89% |
|
-16.51% |
|
-16.51% |
|
-- |
|
-10.29% |
|
-10.31% |
|
$-16.53M |
|
-- |
|
-- |
|
-- |
|
0.30 |
|
0.63 |
|
1.72 |
|
52.28 |
|
-4.66% |
|
-7.49% |
|
-3.10% |
|
-4.66% |
|
$4.16 |
|
$-0.40 |
|
$-0.35 |
|